PHSR Graduate Student Publications and Presentations (2009-2014)

Student Mentor Publications and Presentations

Aly, A.

Mullins, C. D.

Publications: Aly A, Brent C, Chihos V, Clark I, El Ghaziri M, Mansdorf D, Mishler O. The Civility Discourse: Where Do We Stand and How Do We Proceed? May 2013 White Paper http://www.umaryland.edu/islsi/pi/Symposium/White%20paper%20final.pdf Soliman A, Hussain, M, Abdulhalim AM. The status of pharmacoeconomics in Egyptian schools of pharmacy. J Pharm Educ. (forthcoming). Lopert R, Shoemaker JS, Stuart B, Davidoff A, Shaffer T, Abdulhalim AM, Lloyd J. Impact of Medication Adherence on Medicare Expenditure among Beneficiaries with Congestive Heart Failure. Am J Managed Care. 2012 Sep;18(9):556-63. Mullins CD, Abdulhalim AM, Lavallee D. Continuous patient engagement in comparative effectiveness research. JAMA. 2012 Apr 18; 307(15):1587-8. Grabner M, Johnson W, Abdulhalim AM, Kuznik A, Mullins CD. The Value of Atorvastatin over the Product Life Cycle in the United States. Clinical Therapeutics. 2011; Oct;33(10):1433-43. Epub 2011 Sep 28. Abdulhalim AM, Sammarco V, Jayasekera J, Ogbonna E. Benefits of interdisciplinary learning between PharmD and PhD students. Am J Pharm Educ. 2011 Sep 10;75(7):144. No abstract available. Poster Presentations: Who Benefits Most From Androgen Deprivation Therapy Among Elderly Metastatic Prostate Cancer Patients? Student Poster presentation at the Drug Information Association Annual Meeting, San Diego, CA. June 2014. Burden and timing of first and subsequent skeletal related events (SREs) in us elderly men with metastatic prostate cancer (mPC). Poster presented at International Society for Pharmacoeconomics and Outcomes Research 19th Annual Meeting, Montréal, Québec, Canada. June 2014. Receipt of Colorectal Cancer Screening among Medicare Beneficiaries with Sensory Impairment. Poster presented at International Society for Pharmacoeconomics and Outcomes Research 19th Annual Meeting, Montréal, Québec, Canada. June 2014. Continuous patient engagement in comparative effectiveness research (CER): An application in cardiovascular disease (CVD). Poster presented at International Society for Pharmacoeconomics and Outcomes Research 19th annual meeting, Montréal, Québec, Canada. June 2014. Cumulative incidence of skeletal related events in men with metastatic prostate cancer based on alternative algorithms” Moderated Poster presented at American Urologic Association Annual Meeting, Orlando, FL. May 2014.

Student Mentor Publications and Presentations

Aly, A.

Mullins, C. D. Prevalence of Fractures among Men with Advanced Prostate Cancer. American Society of Clinical Oncology Genitourinary Symposium Annual Meeting, San Francisco, CA. February 2014. Physician Referral Patterns among Men with Advanced Prostate Cancer. American Society of Clinical Oncology Genitourinary Symposium Annual Meeting, San Francisco, CA. February 2014. The Status of Pharmacoeconomics Education in Egyptian Schools of Pharmacy: An Exploratory Analysis. Poster presented at International Society for Pharmacoeconomics and Outcomes Research 17th Annual Meeting, Washington DC, June 2012.

Burcu, M.

Zito, J.

Publications: Burcu M, Zito JM, Ibe A, Safer DJ. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications. J Child Adolesc Psychopharmacol. 2014 Apr;24(3):112-9. Safer D, Rajakannan T, Burcu M, Zito JM. Trends in subthreshold psychiatric diagnoses for youth in community treatment. JAMA Psychiatry. 2014 July (In press). Rajakannan T, Zito JM, Burcu M, Safer D. Pediatric Bipolar Disorder: Subtype trend and impact of behavioral comorbidities. J Clin Med. 2014, 3(1), 310-322. Zito JM, Burcu M, Ibe A, Safer DJ, Magder LS. Antipsychotic Use by Medicaid-insured Youth: Impact of Eligibility and Psychiatric Diagnosis Across a Decade. Psychiatr Serv. 2013 Mar 1;64(3):223-9. Burcu M, Zito JM, Ibe A, Safer DJ. Psychotropic Medication Patterns in Medicaid-insured Youth with Clinician-reported Maltreatment. J Child Fam Stud. 2014 May;23(4):632-40. Rattinger GB, Burcu M, Dutcher SK, Chhabra PT, Rosenberg RB, Simoni-Wastila L, Franey CS, Walker LD, Zuckerman IH. Pharmacotherapeutic Management of Dementia across Settings of Care. J Am Geriatr Soc. 2013 May;61(5):723-33. Natarajan K, Xie Y, Burcu M, Linn DE, Qiu Y, Baer MR. Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication. PLoS One. 2013 Sep 5;8(9):e74653. Natarajan K, Bhullar J, Shukla S, Burcu M, Chen ZS, Ambudkar SV, Baer MR. The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms. Biochem Pharmacol. 2013 Feb 15;85(4):514-24. Burcu M, Baer MR. Emerging Drugs for Acute Myeloid Leukemia. Expert Opinion on Emerging Drugs Xie Y*, Burcu M*, Linn DE, Qiu Y, Baer MR. Pim-1 kinase protects P-glycoprotein from degradation and enables its glycosylation and cell surface expression. Molecular Pharmacology. 2010 Aug;78(2):310-8. (* co-first author) Burcu M, O'Loughlin KL, Ford LA, Baer MR. Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia. Leukemia. 2008 Nov;22(11):2110-5.

Student Mentor Publications and Presentations

Burcu, M.

Zito, J.

Book Chapter: Burcu M, Baer MR. Acquisition of Drug Resistance. In: Cancer-The Outlaw Cell, Third Edition. Oxford University Press. 2012 Apr. ISBN13: 9780841200005. Podium Presentations: Burcu M, Zito JM, Safer DJ. The Impact of Insurance Coverage Type on Antipsychotic Prescribing Practices for ADHD in Youth. NIMH conference on mental health services research (MHSR-2014), NIH Campus, Bethesda, MD. April 24-26, 2014 Posters: Burcu M, Zito JM, Safer DJ. The Impact of Insurance Coverage Type on Antipsychotic Prescribing Practices for ADHD in Youth. NIMH conference on mental health services research (MHSR-2014), NIH Campus, Bethesda, MD. April 24-26, 2014. Burcu M, Alexander GC, Ng X, Harrington D. Validity of survey-based measures for cost-related medication burden. Academy Health Research Meeting. San Diego, CA (2014). Ng X, Quinn CC , Burcu M, Harrington D. Validity of a unidimensional measure for functional disability among community-dwelling Medicare beneficiaries with diabetes. Academy Health Research Meeting. San Diego, CA (2014). Rajakannan T, Burcu M, Zito J, Safer D. National trends in mood disorder subtypes and associated psychotropic medication use in children and adolescents. 61st AACAP Annual Meeting, San Diego, 2014. Rajakannan T, Burcu, M, Zito JM, Safer DJ. National trends in pediatric bipolar disorder subtypes: 1999-2010. NIMH conference on mental health services research (MHSR-2014), NIH Campus, Bethesda, MD. April 24-26, 2014. Zito JM, Burcu M, Safer DJ, Rajakannan T. Psychotropic medications in very young Medicaid-insured children. AACAP Annual conference symposium, Orlando, FL. October 29, 2013. Zito JM, Burcu M, Lemtouni S, Safer DJ, Schmid I, Pamer C, McKean S, Lam C, and Slavin D. Regional Variations in Complex Antipsychotic Medication Regimens in U.S. Foster Care Youth. 29th ICPE, International Society of Pharmacoepidemiology, August 2013, Montreal, Canada. Burcu M, Zito JM, Safer DJ. Antipsychotic Duration of Use Among Medicaid-insured Preschoolers, Young Children, and Adolescents. 29th ICPE, International Society of Pharmacoepidemiology, August 2013, Montreal, Canada. Burcu M, Zito JM, Safer DJ. Interaction of Age and Psychiatric Diagnosis on Antipsychotic Use among Publicly-Insured Youth with ADHD or Disruptive Behavior Disorders. 29th ICPE, International Society of Pharmacoepidemiology, August 2013, Montreal, Canada. Rajannakkan T, Burcu M, Zito JM, Safer DJ. National Patterns of Pediatric Bipolar Disorder and Treatment in Relation to Comorbid Behavioral Conditions. Academy Health Annual Meeting, June 2013, Baltimore, MD USA.

Student Mentor Publications and Presentations

Burcu, M.

Zito, J. Burcu M, Zito JM, Safer DJ. Antipsychotic Duration of Use Among Medicaid-insured Young Children and Adolescents. Academy Health Annual Meeting, June 2013, Baltimore, MD USA. Rajannakkan T, Burcu M, Zito JM, Safer DJ. National Trends in Psychotropic Medications Prescribed for Pediatric Bipolar Disorder with and without Comorbid Behavioral Disorders, 1999-2010. 29th ICPE, International Society of Pharmacoepidemiology, August 2013, Montreal, Canada. Burcu M, Rattinger GB, Luong M, Dutcher SK, Zuckerman IH, Simoni-Wastila L, Franey CS. “Variations in Medication Use Patterns among Dementia Patients across Care-Setting” Gerontological Society of America Annual Meeting, San Diego, CA. November 2012. Burcu M, Ibe A, Safer DJ, Zito JM. “Antipsychotic Use by U.S. Medicaid Insured Youth: Impact of Eligibility and Psychiatric Diagnosis” International Society of Pharmacoepidemiology Annual Meeting, Barcelona, Spain. August 23-26, 2012. Rattinger GB, Burcu M, Zuckerman IH, Dutcher SK, Chhabra PT, Simoni-Wastila L, Walker LD, Franey CS. “Racial Variations in Medication Use among Dementia Patients” Alzheimer's Association International Conference, Vancouver, Canada. July 16, 2012. Rattinger GB, Zuckerman IH, Burcu M, Dutcher SK, Chhabra PT, Simoni-Wastila L, Walker LD, Franey CS. “Variations in Medication Use Patterns among Dementia Patients” Academy Health Annual Meeting, Orlando, FL. June 24-26, 2012. Burcu M, Ibe A, Safer DJ, Zito JM. “Antipsychotic Use in Medicaid-insured Youth: Safety and Policy Implications” American Society of Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, Gaylord National Harbor, MD. March 14-17, 2012. Natarajan K, Burcu M, Maria MR. “The serine/threonine kinase Pim-1 promotes drug resistance mediated by the ATP-binding cassette multidrug resistance protein breast cancer resistance protein (BCRP, ABCG2) by stabilizing higher-order BCRP multimers” American Association for Cancer Research (AACR) Annual Meeting, Orlando, FL. April 2-6, 2011. Natarajan K, Burcu M, Maria MR. “Inhibition of serine/threonine kinase Pim-1 has anti-proliferative effects in acute myeloid leukemia (AML) and sensitizes multidrug resistant cells to chemotherapy” American Society of Hematology (ASH) Annual Meeting, Orlando, FL. December 4-7, 2010, Baer MR, Xie Y, Burcu M, Qui Y. “Pim-1 kinase protects P-glycoprotein from degradation and enables its glycosylation and cell surface expression” American Association for Cancer Research (AACR) Annual Meeting, Washington D.C. April 17-21, 2010. Xie Y, Burcu M, Baer MR. “The serine/threonine kinase Pim-1 stabilizes 130 kDa FLT3 and promotes aberrant signaling through STAT5 in Acute Myeloid Leukemia cells with FLT3 internal tandem duplication: Synergistic apoptosis induction by Pim-1 and FLT3 Inhibitors” American Society of Hematology (ASH) Annual Meeting, New Orleans, LA. December 5-8, 2009.

Chirikov, V.

Shaya, F.

Publications: Chirikov VV, Shaya FT, Howell CD. Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C. Expert Rev Gastroenterol Hepatol. 2014 Aug 9:1-11. [Epub ahead of print] PubMed PMID: 25109401.

Student Mentor Publications and Presentations

Chirikov, V.

Shaya, F.

Khanna N, Shaya F, Chirikov VV, Steffen B, Sharp D. Dissemination and adoption of the advanced primary care model in the Maryland multi-payer patient centered medical home program. J Health Care Poor Underserved. 2014;25(1 Suppl):122-38. doi: 10.1353/hpu.2014.0066. PubMed PMID: 24583492. Johnson W, Shaya FT, Winston R, Laird A, Mullins CD, Chirikov VV, Saunders E. Diabetes control through an educational intervention. Ethn Dis. 2014 Spring;24(2):182-8. PubMed PMID: 24804364. Shaya FT, Chirikov VV, Howard D, Foster C, Costas J, Snitker S, Frimpter J, Kucharski K. Effect of social networks intervention in type 2 diabetes: a partial randomised study. J Epidemiol Community Health. 2014 Apr 1;68(4):326-32. doi: 10.1136/jech-2013-203274. Epub 2013 Dec 2. PubMed PMID: 24297971. Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N. Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare. Pharmacoeconomics. 2014 Jan;32(1):63-74. doi:10.1007/s40273-013-0109-7. PubMed PMID: 24293197. Chirikov VV, Mullins CD, Hanna N, Breunig IM, Seal B, Shaya FT. Multispecialist Care and Mortality in Hepatocellular Carcinoma. Am J Clin Oncol. 2013 Sep 21. PubMed PMID: 24064759. Breunig IM, Shaya FT, Hanna N, Seal B, Chirikov VV, Mullins CD. Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival. Value Health. Jul-Aug 2013;16(5):760-768 Chirikov VV, Stuart B, Zuckerman IH, Christy MR. Physician Specialty Cost Differences of Treating Nonmelanoma Skin Cancer. Ann Plast Surg. 2013 Jun 6.[Epub ahead of print] PubMed PMID: 24503881. Shaya FT, Chirikov VV, Bron M, Howard D, Foster C, Yan X, Khanna N, Warrington VO. Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy. Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):153-60. doi: 10.1586/erp.12.75. PubMed PMID: 23402455. Shaya FT, Chirikov VV, Daniel Mullins C, Shematek J, Howard D, Foster C, Saunders E. Social networks help control hypertension. J Clin Hypertens (Greenwich). 2013 Jan;15(1):34-40. doi: 10.1111/jch.12036. Epub 2012 Nov 26. PubMed PMID: 23282122; PubMed Central PMCID: PMC3580229. Shaya FT, Chirikov VV. Decision support tools to optimize economic outcomes for type 2 diabetes. Am J Manag Care. 2011 Nov;17 Suppl 14:S377-83. PubMed PMID: 22214425. Chirikov, VV. Bayesian evidence synthesis: multi-parameter evidence chains. ISPOR Connections. Nov/Dec 2012; 18(6):26. Presentations: Breunig IM, Shaya FT, Hanna N, Seal B, Chirikov VV, Mullins CD. The Use of Transarterial Chemoembolization for Treating Hepatocellular Carcinoma in the SEER-Medicare Population. Poster. AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013.

Student Mentor Publications and Presentations

Chirikov, V.

Shaya, F.

Shaya FT, Howard D, Foster C, Chirikov VV, Snitker S, Costas J, Kucharski K, Tangirala K, Frimpter J. Social Networks-Based Diabetes Education Improves Social Efficacy and Cohesion, and Favors Sustainability. Poster. AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013. Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N. Treatment Modalities for Hepatocellular Carcinoma: Cumulative Expenditures and Survival in SEER-Medicare. Poster. AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013. Chirikov VV, Mullins CD, Hanna NN, Breunig IM, Seal B, Shaya FT. Multidisciplinary physician care and mortality in hepatocellular carcinoma. Poster. AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013. Breunig IM, Shaya FT, Hanna N, Seal B, Chirikov VV, Mullins CD. The Use of Transarterial Chemoembolization for Treating Hepatocellular Carcinoma in the SEER-Medicare Population. Podium Presentation. ISPOR 18th Annual International Meeting, New Orleans, LA. May 18-22, 2013. Chirikov VV, Mullins CD, Hanna NN, Breunig IM, Seal B, Shaya FT. Multidisciplinary physician care and mortality in hepatocellular carcinoma. Poster. ISPOR 18th Annual International Meeting, New Orleans, LA. May 18-22, 2013. Shaya FT, Chirikov VV, Howard D, Foster C, Snitker S, Costas J, Kucharski K, Tangirala K, Frimpter J. Social Networks Boost Diabetes Education and Reduce HbA1c and Blood Sugar. Poster. ISPOR 18th Annual International Meeting, New Orleans, LA. May 18-22, 2013. Shaya FT, Howard D, Foster C, Chirikov VV, Snitker S, Costas J, Kucharski K, Tangirala K, Frimpter J. Social Networks-Based Diabetes Education Improves Social Efficacy and Cohesion, and Favors Sustainability. Poster. ISPOR 18th Annual International Meeting, New Orleans, LA. May 18-22, 2013. Chirikov VV, Stuart B, Zuckerman IH. Physician-specialty cost differences of treating non-melanoma skin cancer (NMSC): an update. Poster. ISPOR 17th Annual International Meeting, Washington, DC. June 2-6, 2012. Shaya FT, Chirikov VV, Mullins CD. Social networks help control hypertension. Poster. ISPOR 17th Annual International Meeting, Washington, DC. June 2-6, 2012. Shaya FT, Chirikov VV, Breunig IM, Seal B, Hanna NN, Mullins CD. Specialty care and treatment in Medicare HCC patients. Poster. ISPOR 17th Annual International Meeting, Washington, DC. June 2-6, 2012. Shaya FT, Breunig IM, Hanna N, Pandya N, Chirikov VV, Seal B, Mullins CD. Is the Number of TACE Treatments in HCC Patients Associated With Improved Survival?: A SEER- Medicare Population Analysis. Poster. Society of Surgical Oncology (SSO) Annual Meeting, Orlando, FL. March 2012. Shaya FT, Breunig IM, Mullins CD, Pandya NM , Chirikov VV, Seal B, Hanna NN. Comparative analysis of treatments, utilization, and survival benefit in HCC patients: A real-world analysis of SEER Medicare. Poster. ASCO 2012 Gastrointestinal Cancers Symposium. San Francisco. Feb 2-4, 2012.

Student Mentor Publications and Presentations

Chirikov, V. Shaya, F. Shaya FT, Breunig IM, Hanna NN , Pandya NM , Chirikov VV, Seal B, Mullins CD. Is the number of TACE treatments in HCC patients associated with improved survival? A SEER-Medicare population analysis. Poster. ASCO 2012 Gastrointestinal Cancers Symposium. San Francisco. Feb 2-4, 2012.

Hendrick, F.

Stuart, B.

Publications: Hendrick F, Zeidan AM, Gore SD, Baer MR, Davidoff AJ. Effect of erythropoiesis-stimulating agent policy decisions on off-label use in myelodysplastic syndromes. Medicare & Medicaid Research Review. [Accepted]. Davidoff AJ, Zeidan AM, Hendrick F, Stuart BC, Duong V, Baer MR, Shenolikar RA, Gore SD. Utilization impacts of new oral substitutes for parenteral cancer-related therapies. American Journal of Pharmacy Benefits. [Accepted]. Davidoff AJ, Gardner LD, Zuckerman IH, Hendrick F, Ke X, Edelman MJ. Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studies. Medical Care. 2014;52(6):500-510. Davidoff AJ, Weiss SR, Baer MR, Ke X, Hendrick F, Zeidan A, Gore SD. Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines. Leukemia Research. 2013;37(6):675-680. Davidoff AJ, Zuckerman IH, Pandya N, Hendrick F, Ke X, Hurria A, Lichtman SM, Hussain A, Weiner JP, Edelman MJ. A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes. Journal of Geriatric Oncology. 2013;4(2):157-165. Zeidan AM, Gore SD, McNally DL, Baer MR, Hendrick F, Mahmoud D, Davidoff AJ. Lenalidomide performance in the real world: Patterns of use and effectiveness in a Medicare population with myelodysplastic syndromes. Cancer. 2013; 119(21):3870-3878. Zandberg DP, Hendrick F, Vannorsdall E, Bierenbaum J, Tidwell ML, Ning Y, Zhao XF, Davidoff AJ, Baer MR. Tertiary center referral patterns for patients with myelodysplastic syndrome are indicative of age and race disparities: a single-institution experience. Leukemia & Lymphoma. 2013;54(2):304-309. Davidoff A, Weiss Smith S, Baer M, Ke X, Bierenbaum JM, Hendrick F, McNally DL, Gore SD. “Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes.” Haematologica. 2012;97(1):128-132. Stuart B, Davidoff A, Pradel F, Lopert R, Shaffer T, Onukwugha E, Hendrick F, Lloyd J. “Persistence in health behaviors among Medicare beneficiaries.” Open Journal of Preventive Medicine. 2012;2(1):49-58. Oral Presentations: Hendrick F, Davidoff AJ, Zeidan AM, Gore SD, Baer MR. “Association Between FDA Safety Warnings, CMS Coverage Restrictions and Adherence to Guidelines for ESA Use in Patients with Myelodysplastic Syndromes” presented at the 54th Annual Meeting and Exposition of the American Society of Hematology Annual Meeting, Atlanta, GA, December 2012.

Student Mentor Publications and Presentations

Hendrick, F.

Stuart, B.

Presentations: Stuart BC, Hendrick F, Xu J, Dougherty S. Why do LIS recipients have higher Part D spending? 2014 AcademyHealth Annual Research Meeting, San Diego, CA. Davidoff AJ, Hendrick F, Stuart BC, Zeidan AM, Gore SD, Baer MR. The role of Medicare Part D in coverage of injected medications: The case of erythropoiesis-stimulating agents in myelodysplastic syndromes. 2013 AcademyHealth Annual Research Meeting, Baltimore, MD. Davidoff AJ, Hendrick F, Stuart BC, Zeidan AM, Duong V, Baer MR, Gore SD. Availability of oral substitutes for traditional parenteral cancer-related treatments: Impact on therapy initiation, duration, and dose adequacy. 2013 AcademyHealth Annual Research Meeting, Baltimore, MD. Ke X, Davidoff A, Zuckerman I, Pandya N, Hendrick F, Weiss Smith S, Baer M, Gore S. “Claims-based prediction of performance status (PS) associated with erythropoietic stimulating agent (ESA) treatment and survival in myelodysplastic syndromes (MDS) patients.” Leukemia Research (Abstracts of the 11th International Symposium Myelodysplastic Syndromes (MDS)), 35, Supplement 1, May 2011, Page S57. Davidoff A, Baer M, Weiss Smith S, Ke X, Bierenbaum J, Hendrick F, McNally D, Gore S. “The broad use of erythropoietic stimulating agents (ESA) for myelodysplastic syndromes (MDS) in the U.S. is not consistent with guidelines.” Leukemia Research (Abstracts of the 11th International Symposium on Myelodysplastic Syndromes (MDS)), 35, Supplement 1, May 2011, Page S15. Davidoff A, Weiss Smith S, Baer M, Ke X, Bierenbaum M, Hendrick F, McNally D, Gore S. “Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).” Blood (ASH 2010 Annual Meeting Abstracts) 116: 3815. Davidoff A, Zuckerman I, Pandya N, Hendrick F, Ke X, Hurria A, Lichtman S, Hussain A, Edelman M. “Development of a performance status prediction model for use in administrative data analyses.” Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings. Vol 28, No 15_suppl (May 20 Supplement), 2010: 6006. Ke X, Hendrick F, Shaffer T, Davidoff A. “Out-of-pocket (OOP) spending burden for Medicare beneficiaries with cancer.” Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings. Vol 28, No 15_suppl (May 20 Supplement), 2010: 9124. Zeidan A, Hendrick F, Friedmann E, Gore SD, Baer MR, Sasane M, Paley C, McNally DL, Davidoff AJ. Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes, Blood (ASH 2012 Annual Meeting Abstracts) 120(21): 426. Davidoff AJ, Hendrick F, Stuart BC, Zeidan AM, Shenolikar R, Gore SD, Baer MR. Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis. Blood (ASH 2012 Annual Meeting Abstracts) 120(21): 3716.

Student Mentor Publications and Presentations

Hendrick, F.

Stuart, B. Zeidan AM, Gore SD, McNally DL, Baer MR, Hendrick F, Mahmoud D, Davidoff AJ. Lenalidomide Performance in the Real World: Patterns of Utilization and Effectiveness in a Medicare Population with Myelodysplastic Syndromes. Blood (ASH 2012 Annual Meeting Abstracts) 120(21): 3837.

Huang, T-Y

Simoni-Wastila, L.

Publications: Wei YJ, Simoni-Wastila L, Zuckerman IH, Huang TY, Brandt N, Moyo P, Lucas J. Quality of Psychopharmacological Medication on Mortality among Medicare Nursing Home Residents. Journal of the American Geriatrics Society, 2014. (In press) Simoni-Wastila L, Wei YJ, Luong M, Franey C, Huang TJ, Rattinger G, Zuckerman IH, Brandt N, Lucas J. Quality of Psychopharmacological Medication Use in Nursing Home Residents. Res Social Adm Pharm. 2013 Zandberg DP, Huang TY, Ke X, Baer MR, Gore SD, Weiss Smith S, Davidoff AJ. Treatment and Outcomes for Chronic Myelomonocytic Leukemia Compared to Myelodysplastic Syndromes in Older Adults. Haematologica. 2012 Nov 9. Zuckerman IH, Yin X, Rattinger GB, Gottlieb SS, Simoni-Wastila L, Pierce SA, Huang TY, Shenolikar R, Stuart B. Effect of Exposure to Evidence-Based Pharmacotherapy on Outcomes after Acute Myocardial Infarction in Older Adults. J Am Geriatr Soc. 2012 Oct;60(10):1854-61. doi: 10.1111/j.1532-5415.2012.04165.x. Epub 2012 Sep 24. Oral Presentations: Huang TY, Moyo P, Simoni-Wastila L. Effect of Facility Opioid Treatment Availability on Opioid Analgesic Overdose Deaths. The 30th Anniversary International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Taipei, Taiwan, Oct 2014 Huang TY, Moyo P, Simoni-Wastila L. Co-Occurring Mental Illness in Emergency Department and Hospital Inpatient Encounters Related to Substance Abuse in Maryland. 2014 Addiction Health Services Research Conference, Boston, MA, Oct 2014 Huang TY, Wei YJ, Moyo P, Zuckerman IH, Lucas J, Simoni-Wastila L. Treated Behavioral Symptoms and Mortality among Medicare Nursing Home Residents with Alzheimer’s Disease and Related Dementias. 2014 AcademyHealth Annual Research Meeting, San Diego, CA, June 2014 Huang TY, Moyo P, Simoni-Wastila L. Treatment Availability in Substance Abuse Treatment Facilities and Opioid Analgesic Overdose Deaths. 2014 AcademyHealth Student Pecha Kucha Style Competition, San Diego, CA, June 2014 Huang TY, Simoni-Wastila L, Wei YJ, Zuckerman IH, Brandt N, Luong M, Moyo P. Psychopharmacological Medication Use in Nursing Home Residents with Delirium. The 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, QC, Aug 2013 Simoni-Wastila L, Wei YJ, Franey C, Luong M, Rattinger G, Zuckerman IH, Brandt N, Huang TY, Moyo P. Psychopharmacological Medication Use in Nursing Home Residents: Prevalence, Patterns, and Indications of Use. The Gerontological Society of America 65th Annual Scientific Meeting, San Diego, CA. Nov 2012.

Student Mentor Publications and Presentations

Huang, T-Y

Simoni-Wastila, L.

Huang TY, Stuart B, Zuckerman IH “Mental Illness and Preventable Hospitalization” presented at the 2012 Pharmaceutical Health Services Research Seminar, Apr 2012 Poster Presentations: Moyo P, Huang TY, Simoni-Wastila L. Co-Occurring Mental Disorders in Treatment Admissions for Substance Use Disorders in Maryland. 2014 Addiction Health Services Research Conference, Boston, MA, Oct 2014 Moyo P, Huang TY, Simoni-Wastila L. Association of Prescription Opioid Use and Mortality in Community-Dwelling Medicare Beneficiaries with Non-Cancer Conditions. Drug Information Association 2014 Annual Meeting, San Diego, CA, June 2014 Huang TY and Simoni-Wastila L. Where You Live and Who You Are Matter: Prescription Opioid Treatment Admissions (updated data and analysis). 2014 AcademyHealth Annual Research Meeting, San Diego, CA, June 2014 Wei YJ, Simoni-Wastila L, Lucas J, Brandt N, Moyo P, Huang TY, Zuckerman IH. Mortality Risk of Antipsychotic Dose and Duration in Nursing Home Residents with Severe Mental Illness, Delirium, or Behavioral Symptoms in Dementia. 2014 AcademyHealth Annual Research Meeting, San Diego, CA, June 2014 Moyo P, Simoni-Wastila L, Huang TY. Examination of the Factor Structure of Delirium Symptoms among Nursing Home Residents. 2014 AcademyHealth Annual Research Meeting, San Diego, CA, June 2014 Moyo P, Huang TY, Simoni-Wastila L. Estimates and Characteristics of Emergency Department Visits Involving Prescription Opioids in the U.S. International Conference on Opioids. Boston, MA, June 2014. Huang TY, Yang J, Simoni-Wastila L. Where You Live and Who You Are Matter: Prescription Opioid Treatment Admissions. 2013 Esri Health GIS, Cambridge, MA, Oct 2013 Huang TY, Wei YJ, Moyo P, Zuckerman IH, Lucas J, Simoni-Wastila L. Association of Behavioral Symptom Improvement with Mortality among Medicare Nursing Home Residents with Alzheimer’s Disease and Related Dementias. The 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, QC, Aug 2013 Huang TY, Wei YJ, Simoni-Wastila L, Moyo P, Zuckerman IH, Lucas J. Factors Associated with Behavioral Symptom Improvement among Medicare Nursing Home Residents with Alzheimer’s Disease and Related Dementias. 2013 AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013 Wei YJ, Simoni-Wastila L, Huang TY, Moyo P, Franey C, Brandt N, Zuckerman IH. Impact of Psychopharmacological Medication Use and Quality On Mortality Among Medicare Nursing Home Residents. 2013 AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013 Moyo P, Wei YJ, Huang TY, Yang J, Woods C, Simoni-Wastila L. Opioid-related Hospital Admissions and Deaths in Maryland, 2008-2011. 2013 AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013

Student Mentor Publications and Presentations

Huang, T-Y Simoni-Wastila, L.

Simoni-Wastila L, Wei YJ, Luong M, Franey C, Huang TY, Rattinger G, Zuckerman IH, Brandt N. Antipsychotic and Other Psychopharmacological Medication Use in Nursing Home Residents with Delirium. The Gerontological Society of America 65th Annual Scientific Meeting, San Diego, CA. Nov 2012. Simoni-Wastila L, Wei YJ, Franey C, Luong M, Rattinger G, Zuckerman IH, Brandt N, Huang TY. Psychopharmacological Medication Use in Nursing Home Residents: Prevalence, Patterns and Indications of Use. 2012 AcademyHealth Annual Research Meeting, Orlando, FL. June 2012 Huang TY, Luong M, Wei YJ, Franey C, Rattinger G, Brandt N, Pyhtila J, Zuckerman IH, Simoni-Wastila L. Psychopharmacological Medication Use in Nursing Home Residents: Prevalence, Patterns and Indications of Use. 2012 University of Maryland, Graduate Research Conference, Mar 2012

Jayasekera, J.

Onukwugha, E.

Publications: Onukwugha E, Osteen P, Jayasekera J, Mullins CD, Mair CA, Hussain A. Racial disparities in urologist visits among elderly men with prostate cancer: A cohort analysis of patient-related and county of residence-related factors. Cancer. Jun 24 2014. Jayasekera J., Onukwugha E., Bikov K., Mullins C.D., Seal B., Hussain A., The Economic Burden of Skeletal Related Events among Elderly Men with Metastatic Prostate Cancer. PharmacoEconomics. DOI: 10.1007/s40273-013-0121-y Abdulhalim, A.M., Sammarco V., Jayasekera J., Benefits of interdisciplinary learning between PharmD and PhD students. 2011. Am J Pharm Educ. 75(7): p. 144. Poster presentations: Jayasekera J., Onukwugha E., Racial disparities in context: A multilevel analysis of early treatment patterns among men with high risk prostate cancer, 36th Annual Meeting of the Society for Medical Decision Making, Medical Decision Making among Diverse Populations: Advancing Practice, Policy, and Science, October 18 - 22, 2014, Miami, FL. Onukwugha E., Jayasekera J., Racial disparities in context: A multilevel analysis of conservative management in men with low risk prostate cancer, 36th Annual Meeting of the Society for Medical Decision Making, Medical Decision Making Among Diverse Populations: Advancing Practice, Policy, and Science, October 18 - 22, 2014, Miami, FL. Jayasekera J., Onukwugha E., Effects of the Primary Payer Type and Race/Ethnicity on Prostate Cancer Screening Practices during Preventive Health Exams in US Ambulatory Care Settings, ISPOR 19th Annual International Meeting, May 31- June 4, 2014, Montréal Montreal, QC, Canada. Onukwugha E., Qi R., Jayasekera J., Zhou S., Predicting High Cost Accumulation: Application of a Grouping Algorithm for Survival Data, ISPOR 19th Annual International Meeting, May 31- June 4, 2014, Montréal Montreal, QC, Canada. Jayasekera J., Onukwugha E., Defining ‘Integrated Care’ and ‘Accessibility from an Ambulatory Health Care Provider Perspective, Geneva Health Forum: Global Health, Interconnected Challenges, Integrated Solutions, April 15-17 2014, Geneva, Switzerland.

Student Mentor Publications and Presentations

Jayasekera, J. Onukwugha, E.

Jayasekera J., Onukwugha E., Racial Differences in Prostate Cancer Screening Practices in US Ambulatory Care Settings Prior to and Following US Preventive Services Task Force Recommendations in 2008 The Science of Cancer Health Disparities in Ethnic Minorities and the Medically Underserved, December 6-9, 2013 in Atlanta, GA. Jayasekera J., Onukwugha E., Bikov K., Mullins C.D., Seal B., Hussain A., A Cost Analysis of Skeletal Related Events Among Elderly Men with Stage IV Metastatic (M1) Prostate Cancer. Drug Information Association 2013, 49th Annual Meeting, June 23 – 27, 2013 at the Boston Convention and Exhibition Center, Boston, MA. Award: Lee B. Lusted Student Prize in the Applied Health Economics Category. Jayasekera J., Stuart B., Zuckerman I., Antidepressant Use and Falls among Community-Dwelling Elderly Medicare Beneficiaries. Academy Health’s 2013 Annual Research Meeting (ARM), June 23-25 at the Baltimore Convention Center. Jayasekera J., Cost Effectiveness Analysis of Diclofenac Potassium Oral Solution. Pharmaceutical Life Cycle Conference 2013, September 2-4 at University of Amsterdam. Jayasekera J., Onukwugha E., Bikov K., Mullins C.D., Seal B., Hussain A., Cost analysis of skeletal related events among men with stage IV metastatic prostate cancer in SEER-Medicare. ISPOR 18th Annual International Meeting to be held May 18-22, 2013 at the Sheraton New Orleans in New Orleans, LA, USA Onukwugha E, Mullins CD, Osteen P, Jayasekera J, Hussain A; “African American (AA) race, crime rates, and treatment receipt among men with prostate cancer (PCa)." 2012 CDC National Cancer Conference: Uniting Systems, Policy & Practice in Cancer Prevention and Control. Hussain A, Onukwugha E, Jayasekera J, McNally D, Seal B, Mullins CD: “Characteristics of stage III and IV M0 prostate cancer (PCa) patients in SEER-Medicare who develop bone metastasis (BM) following diagnosis.” 2012 ASCO Annual Meeting. Abstract No:e15146; Citation:J Clin Oncol 30, 2012 (suppl; abstr e15146) Onukwugha E, Osteen P, Jayasekera J, Mullins CD, Modifiable factors explaining disparities in urologist visits among prostate cancer patients in SEER-Medicare. Science of Eliminating Health Disparities Summit. December 2012 Baltimore, Maryland.

Khokhar, Bilal Simoni-Wastila, L. Publications: Shen X, Dutcher SK, Palmer JB, Liu X, Kiptanui Z, Khokhar B, Al-Jawadi MH, Zhu Y, Zuckerman IH. A Systematic Review of Benefits and Risks of Anticoagulation Following Traumatic Brain Injury. J Head Trauma Rehabil. (In press). Albrecht JS, Kiptanui Z, Tsang Y, Khokhar B, Liu X, Simoni-Wastila L, Zuckerman IH. Depression among Older Adults Following Traumatic Brain Injury: A National Analysis. American Journal of Geriatric Psychiatry. 2014 (accepted for publication) Presentations: Liu, X., Baumgarten M., Smith, G., Gottlieb, S., Franey, C., Khokhar, B., Rattinger, G., Zuckerman, I. Warfarin usage in elderly atrial fibrillation patients who experienced traumatic brain injury. Poster session presented at: GSA Annual Scientific Meeting. 66th

Student Mentor Publications and Presentations

Annual Conference of the Gerontological Society of America; 2013 Nov 20-24; New Orleans, Louisiana. Shen, X., Dutcher, S., Palmer, J., Liu, X., Al-Jawadi, M., Khokhar, B., Kiptanui, Z., Zhu, Y. A systematic review on benefits and risks of anticoagulant use post traumatic brain injury. Poster session presented at: GSA Annual Scientific Meeting. 66th Annual Conference of the Gerontological Society of America; 2013 Nov 20-24; New Orleans, Louisiana. Best Student Poster “The risk of stroke among elderly antidepressant users with incident depression following traumatic brain injury following traumatic brain injury” Graduate Research Conference, March, 2014 University of Maryland Baltimore, Baltimore, Maryland, Best Student Abstract “The risk of stroke among elderly antidepressant users who have suffered a traumatic brain injury: a nested-cohort study” Academy Health Annual Research Meeting, June 2014, San Diego

Loh, F-H.

Stuart, B.

Publications: Stuart B., Loh F.E., Roberto P.N., Miller L. “Incident User Cohorts to Assessing Medication Cost-Offsets.” Health Services Research. 2014;49(4):1364-86. Stuart B., Loh F.E., Magder L., Park J., Zacker C. “Anticipating Changes in Drug Coverage: How Elderly Heart Failure Patients Respond to Medicare Part D Benefit Phases.” Journal of Pharmaceutical Care and Health Systems. 2014;1(1). doi: 10.4172/jpchs.1000104. Stuart B., Loh F.E., Xu J., Roberto P.N., Shoemaker J.S. “Chartbook of Medication Utilization Patterns and Outcomes among Part D Enrollees with Common Chronic Diseases.” PhRMA. 2014. http://www.pharmacy.umaryland.edu/centers/lamy/pdf/Part_D_Chartbook_Final_2014.pdf Stuart B., Loh F.E., Miller L., Roberto P.N. “Should Eligibility for Medication Therapy Management Be Based on Drug Adherence?” Journal of Managed Care Pharmacy. 2014;20(1):66-75. Stuart B., Loh F.E., Roberto P.N., Miller L. “Increasing Medicare Part D Enrollment in Medication Therapy Management Could Improve Health and Lower Costs.” Health Affairs. 2013;32(7):1212-20. Stuart B., Loh F.E. “Response Letter to Jonathan Harding.” Journal of the American Geriatrics Society. 2013;61(2):310. Onukwugha E., Saunders E., Mullins C.D. Pradel F.G., Zuckerman M., Loh F.E., Weir M.R. “Reasons for Discharges Against Medical Advice in the Cardiovascular Setting.” BMJ Open. 2012; Vol. 2(4). Stuart B., Loh F.E. “Medicare Part D Enrollees’ Use of Out-of-Plan Discounted Generic Drugs” Journal of the American Geriatrics Society. Feb. 2012;Vol. 60(2): 387-388. Onukwugha E., Mullins C.D., Loh F.E., Saunders E., Shaya F, Weir M. “Readmissions after Unauthorized Discharges in the Cardiovascular setting.” Medical Care. 2011; Vol.49(2): 215-24.

Student Mentor Publications and Presentations

Loh, F-H.

Stuart, B.

Wertheimer A.I., Loh F.E. “Getting Value from End-of-Life-Cycle Pharmaceuticals.” Pharmaceutical Commerce. Dec. 2009; Vol. 19(3). Wertheimer A.I., Loh, F.E. “Making Pharmaceuticals Affordable in Lesser Developed Countries: A Public Health Role for the Pharmacist.” Journal of Public Health Pharmacy. 2008; Vol. 1(1):3-15. Wertheimer A.I., Loh, F.E., Poli L.G. “Lifecycle: End Game.” Pharmaceutical Executive. Oct. 2007; Vol. 27(10). Wertheimer A.I., Loh, F.E. “Getting Better?” Pharmaceutical Executive. Aug. 2006; Vol. 26(8): 72-84. B o o k C h a p t e r : Loh F.E. “The financial and Economic Aspects of Counterfeit Medicines.” In Counterfeit Medicines: Policy, Economics and Countermeasures. Ed. Albert I. Wertheimer and Perry G. Wang. ILM Publications, Hertfordshire, UK, 2012. B o o k R e v i e w : Loh F.E. Book Review of “Drugs for Less: The Complete Guide to Free and Discounted Prescription Drugs, Featuring More Than 600 of The Most Commonly Prescribed Medications”, by Michael P. Cecil, MD. New York: Hatherleigh Press, 2005. Journal of Pharmaceutical Finance, Economics and Policy. 2007;15(2):121-23. P r e s e n t a t i o n s : Loh F.E. “Use and Patterns of Osteoporosis Pharmacotherapy in Medicare Beneficiaries with Osteoporosis.” The Gerontological Society of America Annual Scientific Meeting, Washington, DC, Nov. 2014. Loh F.E. “Comparing Use of Osteoporosis Medications in Female and Male Medicare Beneficiaries with Osteoporosis.” ISPOR Asia-Pacific Meeting, Beijing, China, Sep. 2014. Loh F.E. “Use of Evidence-Based Medications in Treating Medicare Beneficiaries with Osteoporosis.” DIA Annual Meeting, San Diego, California, Jun. 2014. Loh F.E. “Use and Patterns of Osteoporosis Pharmacotherapy on Community-Dwelling and Long-Term Care Facility-Residing Medicare Beneficiaries with Osteoporosis.” AcademyHealth Annual Research Meeting, San Diego, California, Jun. 2014. Stuart B., Dai M., Xu J., Loh F.E., Dougherty J.S. “Does Good Medication Adherence Really Save Payers Money?” AcademyHealth Annual Research Meeting, San Diego, California, Jun. 2014. Stuart B., Loh F.E., Roberto P., Miller L. “Incident User Cohorts to Assessing Medication Cost-Offsets.” AcademyHealth Annual Research Meeting, Baltimore, Maryland, Jun. 2013.

Student Mentor Publications and Presentations

Loh, F-H.

Stuart, B. Stuart B., Loh F.E., Roberto P., Miller L. “Medication Adherence, Medicare Costs, and Targeting Medication Therapy Management Services.” AcademyHealth Annual Research Meeting, Baltimore, Maryland, Jun. 2013. Stuart B., Loh F.E., Miller L., Roberto P. “Longitudinal Patterns in Drug Utilization among Medicare Part D Enrollees with Chronic Disease: Lessons for Medication Therapy Management Programs.” AcademyHealth Annual Research Meeting, Orlando, Florida, Jun. 2012. Loh F.E., Stuart B. “Patterns of Treatment Utilization for Osteoporosis in Elderly Women Residing in the Community and in Long-Term Care Facilities.” ISPOR 16th Annual International Meeting, Baltimore, MD, May 2011. Onukwugha E., Saunders E., Mullins C.D., Pradel F., Zuckerman M., Loh F.E., Weir M. “Reasons for Discharges Against Medical Advice in the Cardiovascular Setting: A Qualitative Analysis.” Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C., May 2010. Onukwugha E., Mullins C.D., Loh F.E., Saunders E., Shaya F., Weir M. “Costs Associated with Discharges Against Medical Advice in a Cardiovascular Population.” ISPOR 15th Annual International Meeting, Atlanta, GA, May 2010. Onukwugha E., Mullins C.D., Loh F.E., Saunders E., Shaya F., Weir M. “Readmissions after Unauthorized Discharges in the Cardiovascular setting.” ISPOR 15th Annual International Meeting, Atlanta, GA, May 2010.

Moyo, P.

Simoni-Wastila, L.

Publications: Wei YJ, Simoni-Wastila L, Zuckerman IH, Huang TY, Brandt N, Moyo P, Lucas JA. Quality of Psychopharmacological Medication Prescribing and Mortality in Medicare Beneficiaries in Nursing Homes. J Am Geriatr Soc. 2014. Moyo P, Huang TY, Simoni-Wastila L. Association of Prescription Opioid Use and Mortality in Community-Dwelling Medicare Beneficiaries with Non-Cancer Conditions – Abstract. Therapeutic Innovation & Regulatory Science. July 2014. Takahashi K, Ohtani K, Larvie M, Moyo P, Chigweshe L, Van Cott EM, Wakamiya N. Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC). J Thromb Thrombolysis. 2014 Jan 29. Takahashi K, Moyo P, Chigweshe L, Chang WC, White MR, Hartshorn KL. Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study. Virus Res. 2013 Dec 26;178(2):495-501. Simoni-Wastila L, Woods C, Fornili K, Huang TY, Moyo P, Klein-Schwartz W, Wei YJ, Yang J. Substance Use and Outcomes: Maryland State Epidemiological Outcomes Profile 2013. http://www.pharmacy.umaryland.edu/programs/seow/PDF_2013/SubstanceUseAndOutcomesTrendsInMaryland_FINAL_20130924.pdf Published online on 25 September 2013.

Student Mentor Publications and Presentations

Moyo, P.

Simoni-Wastila, L. Takahashi K, Kurokawa K, Moyo P, Jung DJ, An JH, Chigweshe L, Paul E, Lee BL. Intradermal immunization with wall teichoic acid (WTA) elicits and augments an anti-WTA IgG response that protects mice from methicillin-resistant Staphylococcus aureus infection independent of mannose-binding lectin status. PLoS One. 2013;8(8):e69739. doi: 10.1371/journal.pone.0069739. Takahashi K, Chang W, Moyo P, White M, Meelu P, Verma A, Stahl G, Hartshorn K, Yajnik V. “Dietary sugars inhibit biologic functions of the pattern recognition molecule, mannose-binding lectin.” Open Journal of Immunology. Vol.1, No.2, 41-49 (2011). Chang W, White M, Moyo P, McClear S, Thiel S, Hartshorn K, Takahashi K “Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection.” BMC Immunol. 2010 Dec 23;11:64. Chang W, Hartshorn K, White M, Moyo P, Michelow I, Koziel H, Kinane B, Schmidt E, Fujita T, Takahashi K. “Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin.” Biochem Pharmacol. 2011 Feb 1;81(3):388-95. Epub 2010 Oct 28. Presentations: Moyo P, Huang TY, Simoni-Wastila L. Estimates and Characteristics of Emergency Department Visits Involving Prescription Opioids in the U.S. International Conference on Opioids. Boston, MA, June 2014. (poster) Moyo P, Simoni-Wastila L, Huang TY. Examination of the Factor Structure of Delirium Symptoms among Nursing Home Residents. 2014 AcademyHealth Annual Research Meeting, San Diego, CA, June 2014. (poster) Moyo P, Huang TY, Simoni-Wastila L. Association of Prescription Opioid Use and Mortality in Community-Dwelling Medicare Beneficiaries with Non-Cancer Conditions. Drug Information Association 2014 Annual Meeting, San Diego, CA, June 2014. (poster) Moyo P, Huang TY, Simoni-Wastila L. Co-Occurring Mental Disorders in Treatment Admissions for Substance Use Disorders in Maryland. 2014 Addiction Health Services Research Conference, Boston, MA, Oct 15-17, 2014. Moyo P, Huang TY, Simoni-Wastila L. Trends in Prescription Opioid Use among Medicare Part D Enrollees, 2007-2009. AcademyHealth Annual Research Meeting. June 23, 2013. Baltimore, Maryland. (poster) Moyo P, Huang TY, Simoni-Wastila L. Opioid-related Hospital Admissions and Deaths in Maryland, 2008-2011. AcademyHealth Annual Research Meeting. June 24, 2013. Baltimore, Maryland. (poster)

Ng, X.

dosReis, S.

Publications: Ross M, Bridges JFP, Ng X, Wagner L, Frosch E, Reeves G, dosReis S. A Best-Worst Scaling Experiment to Prioritize Caregiver Concerns with Attention-Deficit/Hyperactivity Disorder (ADHD) Medicine. Psychiatric Services (accepted for publication on 17Jul2014. Ng X, Low A, Chew LC, Chong YY, Fong KY, Lui NL, Sim E, Tan YK, Yoong J, Thumboo J. Disease Patterns of Patients seen at Rheumatology Specialist Outpatient Clinics in a Tertiary Hospital in Singapore. International Journal of Rheumatic Diseases. 2013 June;16(3): 273-8

Student Mentor Publications and Presentations

Ng, X.

dosReis, S.

Ng X, Thumboo J, Low A. “Validation of the Scleroderma Health Assessment Questionnaire and Quality of Life in English and Chinese-speaking patients with Systemic Sclerosis.” International Journal of Rheumatic Diseases. 2012 Jun;15(3):268-76. Low AH, Wong S, Thumboo J, Ng SC, Lim JY, Ng X, Earnest A, Fong KY. Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibodies in an Asian population. Rheumatology. doi: 10.1093/rheumatology/kes055 Oral Presentation: Ng X, Bridges JFP, Ross M, Zhou M, Frosch E, Reeves G, dosReis S. Treatment Prioritization using Two Preference-Elicitation Methods: Best-Worst Scaling versus Simple Rating. Academy Health Annual Research Meeting. Student Pecha Kucha Competition 3rd place. San Diego, CA (2014) Ross M, Amuwo O, Ng X, Bridges, JFP, Frosch EF, Reeves G, dosReis S. Using Best-Worst Scaling to Prioritize Caregivers’ Concerns with Initiating ADHD Medicine for Their Child. 22nd NIMH Conference on Mental Health Services Research. Bethesda, MD. (non-presenting author) Ng X, Wee H, Cheung Y, et al. “Factors Associated with Health Services Utilization in Community Dwelling Subjects in Singapore.” Singhealth-Duke NUS Congress 2010. Poster Presentations: Ng X, Bridges JFP, Ross M, Zhou M, Frosch E, Reeves G, dosReis S. Caregivers’ Preferences for Treatment Options in Attention Deficit Hyperactivity Disorder (ADHD): A Best-Worst Scaling Study. Society of Medical Decision Making Annual North American Meeting. Miami, FL (2014) Ng X, Quinn CC , Burcu M, Harrington D. Validity of a unidimensional measure for functional disability among community-dwelling Medicare beneficiaries with diabetes. Academy Health Research Meeting. San Diego, CA (2014) Burcu M, Alexander GC, Ng X, Harrington D. Validity of survey-based measures for cost-related medication burden. Academy Health Research Meeting. San Diego, CA (2014) Ng X, Bridges JFP, Frosch E, Reeves G, dosReis S. Exploring Preferences for Evidence-Based Treatments For Attention Deficit Hyperactivity Disorder (ADHD) from a Patient-Centered Perspective. Academy Health Research Meeting. Baltimore, MD (2013). Ng X, Bridges JFP, Frosch E, Reeves G, dosReis S. Caregiver decision-making for Attention Deficit Hyperactivity Disorder (ADHD) treatment: preference elicitation using a discrete choice experiment. Society of Medical Decision Making Annual North American Meeting. Baltimore, MD (2013) Ng X, Deepak J, Davidoff A. The role of pulmonologist management of prevalent chronic obstructive pulmonary disease in treatment and outcomes for newly diagnosed lung cancer. Academy Health Research Meeting. Baltimore, MD (2013).

Student Mentor Publications and Presentations

Ng, X.

dosReis, S. Ng, X., Das,S., Guan, A., dosReis, S. Antipsychotic use for youth with ADHD and psychiatric comorbidities. Annual Meeting of the International Society for Pharmacoepidemiology. Montreal, Canada (2013). Deepak J, Ng X, Feliciano J, Mao L, Davidoff A. Pulmonologist Management Of Chronic Obstructive Pulmonary Disease And Receipt Of Recommended Treatment For Newly Diagnosed Non-Small Cell Lung Cancer. American Thoracic Society International Conference. Philadelphia, PA (2013) Park, A. Ng, X, dosReis, S. Using caregiver stated preferences to optimize pharmacotherapy regimens for children with attention-deficit/hyperactivity disorder (ADHD). Annual Mid-Year Meeting of the American Society of Hospital Pharmacists. Orlando, FL (2013). Li, J, Ng, X, dosReis, S. Identifying Opportunities to Optimize Treatment Adherence of Children with Attention Deficit/Hyperactivity Disorder (ADHD) through Patient-Centered Medication Therapy Monitoring. Annual Mid-Year Meeting of the American Society of Hospital Pharmacists. Orlando, FL (2013). Amuwo, O., Ross, M., Ng, X., dosReis, S. Treatment beliefs of caregivers of children with attention-deficit/hyperactivity disorder (ADHD). Maryland Pharmacist’s Association MTM Summit. Baltimore, MD (2013). Vannorsdall EJ., Duong VH, Ng X, Zandberg DP, Tidwell ML, Davidoff AJ, Baer MR. “Short Survival and High Rates of Transformation Prevail in Chronic Myelomonocytic Leukemia Despite Hypomethylating Agent Therapy” 2012 Annual Meeting of the American Society of Hematology, Atlanta, Georgia, Dec 2012 Ng X, Low A, Thumboo J. “Comparison of the Charlson Comorbidity Index derived from Self-Report and Medical Record Review.” Singapore General Hospital Annual Scientific Meeting 2011. Ng X, Low A, Chew L, et al. “Disease Patterns of Patients seen at Rheumatology Specialist Outpatient Clinics in a Tertiary Hospital in Singapore.” Singapore General Hospital Annual Scientific Meeting 2011. Ng X, Chan A. Tan Y, et al. “Validation of FACT-Lym Questionnaire among English- and Chinese-speaking Patients with Diffuse Large B Cell Lymphoma in Singapore.” Singapore Pharmacy Congress 2009.

Pennap, D. Zito, J. Publications: Jick S, Pennap D. Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease. Contraception Volume 86, Issue 3, 2012 Poster Presentations: Pennap D, Burcu M, Zito J. Racial/Ethnic Differences in Pediatric Antipsychotic Use by FDA Labeled Status. Annual Maryland Centers of Excellence in Regulatory Science and Innovation M-CERSI 2013

Roberto, P.

Stuart, B.

Publications: Stuart B, Loh FE, Roberto PN, Miller L. “Incident User Cohorts for Assessing Medication Cost-Offsets.” Health Services Research. 2014;49(4):1364-86.

Student Mentor Publications and Presentations

Roberto, P.

Stuart, B. Stuart B, Loh FE, Miller L, Roberto PN. “Should Eligibility for Medication Therapy Management Be Based on Drug Adherence.” Journal of Managed Care Pharmacy. 2014;20(1):66-75. Stuart B, Loh FE, Roberto PN, Miller L. “Increasing Medicare Part D Enrollment in Medication Therapy Management Could Improve Health and Lower Costs.” Health Affairs. 2013; 32(7):1212-1220. Roberto PN, Mitchell JM, Gaskin, DJ. “Plan Choice and Changes in Access to Care Over Time for SSI-Eligible Children with Disabilities.”Inquiry.2005;42(2):145-59. Presentations: Roberto PN, Stuart B. “Out-of-Plan Medication Use in Medicare Part D.” AcademyHealth Annual Research Meeting, San Diego, California, Jun. 2014. Stuart B, Loh FE, Roberto PN, Miller L. “Incident User Cohorts For Assessing Medication Cost-Offsets.” AcademyHealth Annual Research Meeting, Baltimore, Maryland, Jun. 2013 Stuart B, Loh FE, Roberto PN, Miller L. “Medication Adherence, Medicare Costs, and Targeting Medication Therapy Management Services.” AcademyHealth Annual Research Meeting, Baltimore, Maryland, Jun. 2013. Stuart B, Loh FE, Miller L, Roberto PN. “Longitudinal Patterns in Drug Utilization among Medicare Part D Enrollees with Chronic Disease: Lessons for Medication Therapy Management Programs.” AcademyHealth Annual Research Meeting, Orlando, Florida, Jun. 2012. Foley KA, Carls G, Roberto PN. “Medication Adherence and Medical Cost Offsets: A Review of the Literature.” International Society of Outcomes Research 17th Annual Meeting, Washington, DC. June 2012.

Ross, M.

dosReis, S.

Publications: Ross M, Bridges J, Ng X, Wagner L, Frosch E, Reeves G, dosReis S. A Best-Worst Scaling Choice Experiment to Prioritize Caregivers’ Concerns with Initiating Medicine for Attention-Deficit/Hyperactivity Disorder (ADHD). Psychiatric Services. 2014, in press. Kauffman KS, dosReis S, Ross M, Barnet B, Onukwugha E, Mullins CD. Engaging hard-to-reach patients in patient-centered outcomes research. Journal of Comparative Effectiveness Research. 2013;2(3):313-324. Oral Presentations: Ross M, Amuwo O, Ng X, Bridges J, Wagner L, Frosch E, Reeves G, dosReis S. Using Best-Worst Scaling to Prioritize Caregivers’ Concerns with Initiating ADHD Medicine for Their Child. The 22nd NIMH Conference on Mental Health Services Research (MHSR) Research in Pursuit of a Learning Mental Health Care System, Bethesda, Maryland. April 23-25 (podium presentation).

Student Mentor Publications and Presentations

Ross, M. dosReis, S. Poster Presentations: Ross M, Bridges JFP, Ng X, Frosch E, Reeves G, dosReis S. Prioritizing Caregivers’ Concerns with Initiating ADHD Medicine for Their Child: A Best Worst Scaling Preference Elicitation Study. Poster session presented at: Society for Medical Decision Making. 36th Annual North American Meeting; 2014 October 18-22; Miami, FL. Ng X, Bridges JFP, Ross M, Zhou M, Frosch E, Reeves G, dosReis S. Caregivers’ Preferences for Treatment Options in Attention Deficit Hyperactivity Disorder (ADHD): A Best-Worst Scaling Study. Poster session presented at: Society for Medical Decision Making. 36th Annual North American Meeting; 2014 October 18-22; Miami, FL. Amuwo O, Ross M, Ng X, dosReis S. Treatment beliefs of caregivers of children with attention-deficit/hyperactivity disorder (ADHD). Maryland Pharmacist’s Association MTM Summit. Baltimore, MD (2013).

Shen, X.

Stuart, B.

Publications: Garg V, Shen X, Cheng Y, Raisch D. A Literature Review of Use of Number Needed to Treat (NNT) in Cost Effectiveness Analyses (CEA): Can NNT Increase Relevance of CEA to Clinicians? Accepted with revisions by The Annals of Pharmacotherapy. Oral Presentations: Handal A, Shen X, Rowland A, Skipper B, Sioban H. Occupational and Social Stress among Pregnant Flower Workers in Ecuador. Accepted for a paper presentation at Work, Stress, and Health 2013: Protecting and Promoting Total Worker Health, Los Angeles CA, 2013. Poster Presentations: Shen X, Raisch DW. Evaluating Outcomes from Prenatal Antidepressant Exposure: A Meta-analytic Review. 17th International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting, Washington D.C., 2012. Shen X, Raisch DW. The Impact of Methodology on Results of Observational Studies: An Example from Studies Evaluating Outcomes of Prenatal Antidepressant Exposure. 17th International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting, Washington D.C., 2012. Petersen H, Sood A, Meek P, Shen X, Cheng Y, Belinsky SA, Owen C, Washko G, Pinto-Plata V, Celli B, Tesfaigzi Y. ACE Inhibitor Use Is Associated with Less Decline in Lung Function in Smokers. American Thoracic Society International Conference, San Francisco CA, 2012. Edwards BJ, Nardone B, Raisch DW, McKoy JM, Belknap S, Holbrook JS, Garg V, Shen X, Godinez-Puig V, Trifilio S, Emmanuel R, West DP, Small W, Rosen S. Bisphosphonates and Esophageal Cancer: A RADAR Report. American Society of Clinical Oncology Annual Meeting, Chicago IL, 2012.

Student Mentor Publications and Presentations

Shen, X.

Stuart, B. Godinez-Puig V, Nardone B, West DP, Shen X, Garg V, Raisch DW, Holbrook JS, Belknap S, Barahmani N, Edwards BJ. Denosumab Is Associated With Dermatologic Toxicity in the FDA-AERS Database. Society for Investigative Dermatology Annual Meeting, Raleigh NC, 2012.

Tai, M.H. dosReis, S. Publications: Age-Related Trends in Psychotropic Medication Use Among Very Young Children in Foster Care. Susan dosReis, PhD; Ming-Hui Tai, MS, MHPA; David Goffman, PharmD; Sean E. Lynch, PhD, MSW; Gloria Reeves, MD; Terry Shaw, PhD. Psychiatric Services 2014; doi: 10.1176/appi.ps.201300353 Presentations: Hospitalizations, Emergency Department Visits and Placement Transitions Associated with Antipsychotic use Among Youth in Foster Care. Tai M.H., dosReis S., Desai B., Reeves G., Shaw T. Academy Health Research Meeting. Baltimore, MD (2013). Persistent Antipsychotic Treatment and the Impact on Outpatient, Inpatient, and Emergency Department Services for Youth in Foster Care. Tai M.H., dosReis S., Desai, B., Reeves G., Shaw T. Annual Meeting of the International Society for Pharmacoepidemiology. Montreal, Canada (2013). Examination of 24-Month Antipsychotic Treatment Patterns and Dosing in Pediatric Foster Care Patients: Does Outpatient Treatment Conform with Evidence-Based Guidelines? Gandhi S, Tai MH, dosReis S. Annual Mid-Year Meeting of the American Society of Hospital Pharmacists. Orlando, FL (2013). Community Outpatient Antipsychotic Prescribing for Young Children: Pharmacists’ Opportunities for Translating Evidence into Clinical Practice. Goffman, D., Tai, M., dosReis, S. Annual Mid-Year Meeting of the American Society of Hospital Pharmacists. Las Vegas, NV (2012). Zuckerman, I; Pandya, N; Stuart B; Shaffer, G; Erten, M; Ke X; Shoemaker, J; Tai, MH; Davidoff, A. “Out-of-pocket (OOP) healthcare expenditure burden for Medicare beneficiaries with cancer.” 2012 ASCO Annual Meeting (June 1-5, 2012)

Vandigo, J. Mullins, C. D. Publications: Mullins CD, Vandigo J, Zheng Z, Wicks P. Patient-centeredness in the design of clinical trials. Value in Health. (http://dx.doi.org/10.1016/j.jval.2014.02.012)– In Press (2014). Presentations: Vandigo J, Oloyede E, Abdulhalim A, and Mullins CD. Continuous Patient Engagement in Comparative Effectiveness Research: An Application in Cardiovascular Disease. (PRM148), 19th Annual ISPOR International Meeting. Montreal, QC, Canada. (2014).

Student Mentor Publications and Presentations

Yong, C.

Onukwugha, E.

Publications: Yong C, Onukwugha E, Mullins CD. Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer. Curr Opin Oncol. 2014 May;26(3):274-83. Yong C, Onukwugha E, Mullins CD, Seal B, Hussain A. The use of health services among elderly patients with stage IV prostate cancer in the initial period following diagnosis. J Geriatr Oncol. 2014 Jul;5(3):290-8. Onukwugha E, Yong C, Mullins CD, Seal B, McNally D, Hussain A. Skeletal-related events and mortality among older men with advanced prostate cancer. J Geriatr Oncol. 2014 Jul;5(3):281-9. Zuckerman IH, Davidoff AJ, Erten MZ, Stuart B, Shaffer T, Dougherty JS, Yong C. Use of and spending on supportive care medications among Medicare beneficiaries with cancer. Support Care Cancer. 2014 Mar 23. (Epub ahead of print) Onukwugha E, Yong C, Hussain A, Seal B, Mullins CD. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer. BMC Med Res Methodol. 2014 Jan 2;14:1. Yong C, Fisher D, Sklar G, Li S. “A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.” Int J Antimicrob Agents 2009; 33(1): 46-51. Oral Presentations: Onukwugha E, Yong C, Mullins CD, Seal B, Hussain A. Skeletal-Related Events and Mortality among SEER-Medicare Patients with Metastatic Prostate Cancer: The Implications of Measurement Approach. ISPOR 18th Annual International Meeting, New Orleans, LA, 2013. (Presenting Author). Award: Best Student Podium Presentation. Yong C, Fisher D, Sklar G, Li S. “Cost-effectiveness of Outpatient Parenteral Antibiotic Therapy (OPAT) in Singapore.” 19th Singapore Pharmacy Congress, 2007. Awarded 2nd prize in Oral Presentation (Competitive) Category. Yong C, Wee I, See M. Changi “Use of oral and intravenous N-acetylcysteine for prevention of contrast-induced nephropathy at Changi General Hospital.” General Hospital Annual Scientific Meeting, 2008. Poster Presentations: Yong C, Onukwugha E. Impact of physician visits on bone density testing in men with prostate cancer who receive androgen deprivation therapy. ASCO Quality Care Symposium. Boston, MA, October 17-18, 2014. Hussain A, Yong C, Tkaczuk KHR, Qian Y, Arellano J, Balakumaran A, Liede A, Mullins CD, Onukwugha E. Prevalence of and factors associated with skeletal-related events in older United States women diagnosed with metastatic breast cancer. MASCC/ISOO International Symposium on Supportive Care in Cancer, Miami, FL, June 26-28, 2014.

Student Mentor Publications and Presentations

Yong, C.

Onukwugha, E.

Yong C, Onukwugha E, Mullins CD, Zuckerman IH, Naslund M. Use of bone-modifying agents following androgen deprivation therapy for Medicare non-metastatic prostate cancer patients. ISPOR 19th Annual International Meeting, Montreal, QC, Canada, May 31–June 4, 2014. Yong C, Onukwugha E, Mullins CD, Zuckerman IH, Naslund M. Oral and intravenous bisphosphonate use following androgen deprivation therapy among Medicare beneficiaries with non-metastatic prostate cancer. American Urological Association (AUA) Annual Meeting, Orlando, FL, May 16-21, 2014. Yong C, Onukwugha E, Mullins CD, Abdulhalim AM, Qian Y, Arellano J, Balakumaran A, Liede A, Hussain A. Physician referral patterns among men with advanced prostate cancer. 2014 ASCO Genitourinary Cancers Symposium. San Francisco, CA. Jan 30-Feb 1, 2014. Yong C, Onukwugha E, Naslund M. Effect of physician characteristics and geographical region on post-diagnosis physician contact among patients with prostate cancer. Society for Medical Decision Making Asia-Pacific Conference, Singapore, Singapore, Jan 5-8, 2014. Onukwugha E and Yong C. Variation in the types of physicians visited among men diagnosed with stage IV prostate cancer. 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, Oct 19-23 2013. Onukwugha E, Kwok Y, Yong C, Mullins CD, Seal B, Hussain A. Variation in the Length of Radiation Therapy among Men Diagnosed with Incident Metastatic Prostate Cancer. American Society for Radiation Oncology (ASTRO) 2013 Annual Meeting, Sep 22-25 2013, Atlanta, GA. Yong C, Stuart B, Zuckerman I. Use of diabetes self-management education and its effectiveness in the Medicare population. AcademyHealth Annual Research Meeting, Baltimore, MD, June 23-25 2013. Yong C, Onukwugha E, Mullins CD, Seal B, Hussain A. Differences in provider encounters between metastatic (M1) and non-metastatic (M0) prostate cancer (PCa) patients. 2013 American Urological Association Annual Meeting, San Diego, CA, May 3-5 2013. Yong C, Onukwugha E, Mullins CD, Seal B, Hussain A. “Health services utilization differences between metastatic (M1) and non-metastatic (M0) prostate cancer (PCa) patients.” 2013 ASCO Genitourinary Cancers Symposium, Orlando, FL, February 2013. (Accepted for poster presentation) Onukwugha E, Yong C, Mullins CD, Seal B, Hussain A. “Predictors and prognostic implication of pathologic fracture (PF), spinal cord compression (SCC) and bone surgery (BS) following diagnosis of metastatic prostate cancer (PCa).” 2013 ASCO Genitourinary Cancers Symposium, Orlando, FL, February 2013. (Accepted for poster presentation) Yong C, Shih YCT, Onukwugha E. “Relationship between birthplace and treatment receipt among stage III and stage IV prostate cancer patients.” 2012 Summit on the Science of Eliminating Health Disparities Summit. National Harbor, MD. December 2012.

Student Mentor Publications and Presentations

Yong, C. Onukwugha, E. Onukwugha E, Yong C. “Patient-, hospital-, and county-level predictors of readmissions among patients with cardiovascular disease.” ISPOR 17th Annual International Meeting, Washington DC, 2012. Onukwugha E, Mullins CD, Yong C, Mcnally D, Seal B. “Bone metastasis (BM) based on SEER registry versus Medicare claims among metastatic prostate cancer (PCa) patients in SEER-Medicare.” J Clin Oncol 30, 2012 (suppl; abstr e15148). Yong C, Wee I, See M. “Use of oral and intravenous N-acetylcysteine for prevention of contrast-induced nephropathy in a Singapore hospital.” ACCP/ESCP International Congress on Clinical Pharmacy, Orlando FL, 2009.